Company
Headquarters: Toronto, ON, Canada
CEO: Mr. Yaron Conforti
C$14.2 Million
CAD as of June 1, 2022
US$11.3 Million
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Novamind Inc., a mental health company, builds a network of psychiatry clinics, retreats, and clinical research sites in the United States. The company offers outpatient mental health services, which includes psychotherapy, psychiatric medication management, transcranial magnetic stimulation, and ketamine-assisted psychotherapy; and clinical trial services. It also manages and hosts third-party clinical trials and participates in organized research studies, as well as clinical research for psychedelic medicines. The company is headquartered in Toronto, Canada.
Top 1-year algo backtest: +313.24%
$10,000 in May 2023 would now be $41,324 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Novamind, Inc. has the following listings and related stock indices.
Stock: CSE: NM wb_incandescent